BioNTech SE Sustainability Reports
BioNTech SE is a biotechnology company that develops next-generation immunotherapies and vaccines for cancer and infectious diseases. The company pioneers mRNA-based therapies, next-generation immunomodulators, and antibody-drug conjugates to leverage the human immune system.
Sector: Professional & technical services
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 894500UZJ5LG1F8J1U58
FIGI: BBG00Q70B4L0
17 reports from 2019 to 2026
